James C Cloyd Selected Research

fosphenytoin (Cerebyx)

1/2021	Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
1/2020	The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.
12/2019	Lessons from the Established Status Epilepticus Treatment Trial.
6/2015	Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus.
6/2015	Canine status epilepticus treated with fosphenytoin: A proof of principle study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James C Cloyd Research Topics

Disease

21	Epilepsy (Aura) 10/2018 - 07/2002
11	Seizures (Absence Seizure) 01/2021 - 07/2002
8	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 06/2015
5	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022 - 12/2012
4	Gaucher Disease (Gaucher's Disease) 12/2020 - 07/2013
4	Migraine Disorders (Migraine) 01/2016 - 09/2012
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2013
2	Ataxia (Dyssynergia) 08/2017 - 06/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2015 - 07/2013
1	Disease Progression 01/2022
1	Peroxisomal Disorders (Peroxisomal Disorder) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2021
1	Synucleinopathies 01/2020
1	Lennox Gastaut Syndrome 10/2016
1	Cardiac Arrhythmias (Arrythmia) 12/2015
1	Hypotension (Low Blood Pressure) 12/2015
1	Respiratory Insufficiency (Respiratory Failure) 12/2015
1	Vomiting 06/2013
1	Nausea 06/2013
1	Paresthesia (Dysesthesia) 06/2013
1	Ischemia 03/2013
1	Stroke (Strokes) 03/2013
1	Hypoxia (Hypoxemia) 03/2013

Drug/Important Bio-Agent (IBA)

7	Topiramate (Topamax)FDA LinkGeneric 01/2016 - 09/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
6	Acetylcysteine (Siran)FDA LinkGeneric 12/2021 - 12/2012
6	BenzodiazepinesIBA 01/2021 - 06/2015
6	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 01/2003
6	Phenytoin (Dilantin)FDA LinkGeneric 01/2021 - 07/2008
6	Anticonvulsants (Antiepileptic Drugs)IBA 06/2015 - 01/2003
5	AntioxidantsIBA 12/2021 - 12/2012
5	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2021 - 06/2015
4	Carbamazepine (Tegretol)FDA LinkGeneric 03/2013 - 01/2009
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 12/2019
3	EnzymesIBA 12/2020 - 01/2003
2	Glucosylceramidase (Glucocerebrosidase)IBA 12/2020 - 01/2020
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 08/2015
2	Diazepam (Valium)FDA LinkGeneric 08/2013 - 12/2002
1	Pregnanolone (Allopregnanolone)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	HydrolasesIBA 12/2020
1	GlycosphingolipidsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	SynucleinsIBA 01/2020
1	Baclofen FDA LinkGeneric 08/2017
1	Clobazam (HR 376)IBA 10/2016
1	Lorenzo's oilIBA 01/2016
1	SBE4-beta-cyclodextrinIBA 06/2013
1	CyclodextrinsIBA 06/2013
1	Cytochrome P-450 CYP3AIBA 01/2013
1	Pregnane X ReceptorIBA 01/2013
1	IsotopesIBA 02/2011
1	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 09/2006

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2002
2	Intravenous Administration 01/2021 - 01/2018
1	Intravenous Infusions 06/2015
1	Injections 06/2013
1	Oral Administration 06/2013
1	Catheters 06/2013
1	Home Nursing (Nursing, Home) 07/2002